6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units | European Journal of Hospital Pharmacy

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via EAHP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Section 6: Education and research

6ER-022 Clinical impact of the use of glucocorticoids for the treatment of COVID-19 in intermediate respiratory care units

Free

Online download statistics by month:

Online download statistics by month: March 2023 to October 2024

	Abstract	Full	Pdf
Mar 2023	32	0	4
Apr 2023	67	0	9
May 2023	26	0	3
Jun 2023	10	0	2
Jul 2023	14	0	2
Aug 2023	14	0	1
Sep 2023	12	0	3
Oct 2023	5	0	2
Nov 2023	13	0	3
Dec 2023	11	0	6
Jan 2024	9	0	1
Feb 2024	12	0	0
Mar 2024	12	0	12
Apr 2024	7	0	0
May 2024	6	0	4
Jun 2024	20	0	2
Jul 2024	2	0	2
Aug 2024	4	0	5
Sep 2024	11	0	1
Oct 2024	7	0	4
Total	294	0	66